Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 07 04:00PM ET
293.54
Dollar change
-4.24
Percentage change
-1.42
%
IndexDJIA, NDX, S&P 500 P/E38.88 EPS (ttm)7.55 Insider Own0.24% Shs Outstand537.00M Perf Week2.84%
Market Cap157.79B Forward P/E13.59 EPS next Y21.60 Insider Trans-0.12% Shs Float536.25M Perf Month12.01%
Income4.09B PEG9.48 EPS next Q4.30 Inst Own78.21% Short Float2.13% Perf Quarter-8.06%
Sales33.27B P/S4.74 EPS this Y4.13% Inst Trans-1.07% Short Ratio2.94 Perf Half Y-6.07%
Book/sh10.94 P/B26.82 EPS next Y4.54% ROA4.33% Short Interest11.43M Perf Year-7.13%
Cash/sh22.27 P/C13.18 EPS next 5Y4.10% ROE67.55% 52W Range253.30 - 346.85 Perf YTD12.62%
Dividend Est.9.72 (3.31%) P/FCF25.11 EPS past 5Y-10.10% ROI6.55% 52W High-15.37% Beta0.54
Dividend TTM9.00 (3.07%) Quick Ratio0.95 Sales past 5Y7.71% Gross Margin78.70% 52W Low15.89% ATR (14)6.78
Dividend Ex-DateFeb 14, 2025 Current Ratio1.26 EPS Y/Y TTM-39.39% Oper. Margin26.35% RSI (14)61.35 Volatility3.46% 2.25%
Employees26700 Debt/Eq10.23 Sales Y/Y TTM18.79% Profit Margin12.29% Recom2.31 Target Price316.50
Option/ShortYes / Yes LT Debt/Eq9.62 EPS Q/Q-18.33% Payout119.05% Rel Volume0.87 Prev Close297.78
Sales Surprise2.31% EPS Surprise4.21% Sales Q/Q11.66% EarningsFeb 04 AMC Avg Volume3.89M Price293.54
SMA204.78% SMA507.22% SMA200-3.80% Trades Volume3,388,076 Change-1.42%
Date Action Analyst Rating Change Price Target Change
Dec-10-24Resumed BofA Securities Underperform $256
Nov-15-24Initiated Wolfe Research Peer Perform
Nov-14-24Initiated Citigroup Neutral $335
Oct-17-24Initiated Bernstein Outperform $380
Oct-14-24Downgrade Truist Buy → Hold $320 → $333
Sep-27-24Initiated Cantor Fitzgerald Overweight $405
Aug-07-24Downgrade Wells Fargo Overweight → Equal Weight $320 → $335
May-03-24Upgrade William Blair Mkt Perform → Outperform
May-03-24Upgrade Barclays Underweight → Equal Weight $230 → $300
Mar-28-24Resumed Raymond James Mkt Perform
Today 05:01PM
Feb-07-25 04:01PM
Feb-06-25 04:17PM
Feb-05-25 07:36PM
04:30PM
01:09PM Loading…
01:09PM
09:16AM
07:15AM
06:28AM
04:51AM
02:12AM
12:15AM
Feb-04-25 07:30PM
05:35PM
05:27PM
05:10PM Loading…
05:10PM
04:59PM
04:57PM
04:18PM
04:13PM
04:07PM
04:06PM
04:01PM
02:10PM
Feb-02-25 04:05PM
Jan-31-25 06:30PM
09:15AM
04:02AM
Jan-30-25 09:50AM
Jan-29-25 04:01PM
09:40AM Loading…
09:40AM
Jan-28-25 05:50PM
03:00PM
10:00AM
Jan-27-25 07:17PM
09:00AM
04:16AM
Jan-24-25 04:17PM
08:38AM
Jan-23-25 06:00PM
Jan-21-25 05:34AM
Jan-20-25 07:47AM
04:38AM
Jan-19-25 06:19PM
Jan-18-25 07:05PM
11:03AM
08:20AM
Jan-17-25 05:50PM
09:01AM
08:11AM
07:00AM
Jan-16-25 01:03PM
08:00AM
Jan-14-25 06:00PM
01:04PM
09:50AM
09:00AM
07:25AM
07:18AM
Jan-13-25 10:57AM
09:40AM
09:00AM
Jan-08-25 04:01PM
08:00AM
Jan-07-25 05:50PM
Jan-06-25 06:00PM
12:10PM
07:43AM
Jan-04-25 06:48AM
Jan-03-25 09:00AM
08:30AM
Jan-01-25 07:03AM
Dec-31-24 05:50PM
04:48PM
Dec-30-24 06:00PM
04:36PM
Dec-27-24 02:00AM
Dec-24-24 02:45PM
12:20PM
Dec-23-24 05:50PM
09:00AM
07:22AM
04:32AM
Dec-21-24 07:30AM
Dec-20-24 04:11PM
02:48PM
11:52AM
10:31AM
08:17AM
Dec-19-24 06:20AM
Dec-18-24 09:48PM
Dec-17-24 06:08PM
05:50PM
06:56AM
Dec-16-24 04:09PM
09:28AM
Dec-14-24 10:00AM
Dec-13-24 09:12AM
04:59AM
Dec-12-24 09:45AM
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Graham Jonathan POfficerFeb 07 '25Proposed Sale292.9425,0457,336,682Feb 07 03:05 PM
Grygiel Nancy A.SVP & CCOFeb 05 '25Sale304.471,589483,8087,210Feb 06 08:54 PM
Grygiel Nancy A.OfficerFeb 05 '25Proposed Sale304.471,589483,800Feb 05 12:53 PM
Grygiel Nancy A.SVP & CCOMay 03 '24Sale313.092,117662,8029,883May 03 07:48 PM